Iovance Biotherapeutics Inc banner

Iovance Biotherapeutics Inc
SWB:2LB

Watchlist Manager
Iovance Biotherapeutics Inc Logo
Iovance Biotherapeutics Inc
SWB:2LB
Watchlist
Price: 5.43 EUR 44.22% Market Closed
Market Cap: €1.5B

Wall St Price Targets

2LB Price Targets Summary
Iovance Biotherapeutics Inc

Wall Street analysts forecast 2LB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2LB is 7.28 EUR with a low forecast of 3.51 EUR and a high forecast of 12.76 EUR.

Lowest Forecast
Price Target
3.51 EUR
35% Downside
Average Forecast
Price Target
7.28 EUR
34% Upside
Highest Forecast
Price Target
12.76 EUR
135% Upside
Iovance Biotherapeutics Inc Competitors:
Price Targets
SMCP
SMCP SA
34% Upside
AMP
Amper SA
24% Upside

Revenue
Forecast

N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 29%.

Gross Profit
Forecast

N/A
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
13%
Average Beat
N/A
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
13%
Average Beat

The compound annual growth rate for Gross Profit over the next 8 years is 43%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2LB's stock price target?
Price Target
7.28 EUR

According to Wall Street analysts, the average 1-year price target for 2LB is 7.28 EUR with a low forecast of 3.51 EUR and a high forecast of 12.76 EUR.

What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
29%

The compound annual growth rate for Revenue over the next 8 years is 29%.

What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
43%

The compound annual growth rate for Gross Profit over the next 8 years is 43%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett